114 related articles for article (PubMed ID: 10704943)
1. Inactivation of atrial natriuretic factor-stimulated cyclic guanosine 3',5'-monophosphate (cGMP) in UMR-106 osteoblast-like cells.
Ahlström M; Lamberg-Allardt C
Biochem Pharmacol; 2000 May; 59(9):1133-9. PubMed ID: 10704943
[TBL] [Abstract][Full Text] [Related]
2. Regulation of adenosine 3',5'-cyclic monophosphate (cAMP) accumulation in UMR-106 osteoblast-like cells: role of cAMP-phosphodiesterase and cAMP efflux.
Ahlström M; Lamberg-Allardt C
Biochem Pharmacol; 1999 Oct; 58(8):1335-40. PubMed ID: 10487537
[TBL] [Abstract][Full Text] [Related]
3. Contribution of phosphodiesterase isoenzymes and cyclic nucleotide efflux to the regulation of cyclic GMP levels in aortic smooth muscle cells.
Mercapide J; Santiago E; Alberdi E; Martinez-Irujo JJ
Biochem Pharmacol; 1999 Nov; 58(10):1675-83. PubMed ID: 10535760
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel potent and specific inhibitor of type V phosphodiesterase.
Coste H; Grondin P
Biochem Pharmacol; 1995 Nov; 50(10):1577-85. PubMed ID: 7503759
[TBL] [Abstract][Full Text] [Related]
5. Effect of efflux of guanosine 3',5' cyclic monophosphate (cGMP) on the regulation of intracellular levels of cGMP in the inner medullary collecting duct.
Stoos BA; Garvin JL
Biochem Pharmacol; 1997 Mar; 53(5):631-6. PubMed ID: 9113081
[TBL] [Abstract][Full Text] [Related]
6. Rapid protein kinase A--mediated activation of cyclic AMP-phosphodiesterase by parathyroid hormone in UMR-106 osteoblast-like cells.
Ahlström M; Lamberg-Allardt C
J Bone Miner Res; 1997 Feb; 12(2):172-8. PubMed ID: 9041048
[TBL] [Abstract][Full Text] [Related]
7. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
de Vente J; Markerink-van Ittersum M; Vles JS
J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase inhibition by a gastroprotective agent irsogladine: preferential blockade of cAMP hydrolysis.
Kyoi T; Oka M; Noda K; Ukai Y
Life Sci; 2004 Aug; 75(15):1833-42. PubMed ID: 15302227
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterases 1 and 2 regulate cellular cGMP level in rabbit submandibular gland cells.
Michikawa H; Sugiya H; Yoshigaki T; Fujita-Yoshigaki J; Furuyama S
Int J Biochem Cell Biol; 2005 Apr; 37(4):876-86. PubMed ID: 15694846
[TBL] [Abstract][Full Text] [Related]
10. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
Suvarna NU; O'Donnell JM
J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
[TBL] [Abstract][Full Text] [Related]
11. ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells.
Wyatt TA; Naftilan AJ; Francis SH; Corbin JD
Am J Physiol; 1998 Feb; 274(2):H448-55. PubMed ID: 9486247
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic factor activates cyclic adenosine 3',5'-monophosphate phosphodiesterase in Xenopus laevis oocytes and potentiates progesterone-induced maturation via cyclic guanosine 5'-monophosphate accumulation.
Sandberg K; Bor M; Ji H; Carvallo PM; Catt KJ
Biol Reprod; 1993 Nov; 49(5):1074-82. PubMed ID: 8286573
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase A activity modulates natriuretic peptide-dependent cGMP accumulation in renal cells.
Ledoux S; Dussaule JC; Chatziantoniou C; Ardaillou N; Vandermeersch S; Ardaillou R
Am J Physiol; 1997 Jan; 272(1 Pt 1):C82-9. PubMed ID: 9038814
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of cyclic nucleotide phosphodiesterase isoforms in the media layer of the main pulmonary artery.
Pauvert O; Salvail D; Rousseau E; Lugnier C; Marthan R; Savineau JP
Biochem Pharmacol; 2002 May; 63(9):1763-72. PubMed ID: 12007579
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibition prevents myocardial infarction-induced increase in renal cortical cGMP and cAMP phosphodiesterase activities.
Clauss F; Charloux A; Piquard F; Doutreleau S; Talha S; Zoll J; Lugnier C; Geny B
Fundam Clin Pharmacol; 2015 Aug; 29(4):352-61. PubMed ID: 25939307
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cGMP-phosphodiesterase restores the glomerular effects of atrial natriuretic factor in low sodium diet rats.
Kalinowski L; Szczepanska-Konkel M; Pawelczyk T; Bizon D; Angielski S
Ren Physiol Biochem; 1995; 18(5):254-66. PubMed ID: 8869083
[TBL] [Abstract][Full Text] [Related]
17. Cyclic nucleotide signalling compartmentation by PDEs in cultured vascular smooth muscle cells.
Zhang L; Bouadjel K; Manoury B; Vandecasteele G; Fischmeister R; Leblais V
Br J Pharmacol; 2019 Jun; 176(11):1780-1792. PubMed ID: 30825186
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase type 2 and the homeostasis of cyclic GMP in living thalamic neurons.
Hepp R; Tricoire L; Hu E; Gervasi N; Paupardin-Tritsch D; Lambolez B; Vincent P
J Neurochem; 2007 Sep; 102(6):1875-1886. PubMed ID: 17561940
[TBL] [Abstract][Full Text] [Related]
19. Interaction between cyclic nucleotide second messenger systems in murine Leydig cells.
Hipkin RW; Moger WH
Mol Cell Endocrinol; 1991 Dec; 82(2-3):251-7. PubMed ID: 1665454
[TBL] [Abstract][Full Text] [Related]
20. Selective blockade of phosphodiesterase types 2, 5 and 9 results in cyclic 3'5' guanosine monophosphate accumulation in retinal pigment epithelium cells.
Diederen RM; La Heij EC; Markerink-van Ittersum M; Kijlstra A; Hendrikse F; de Vente J
Br J Ophthalmol; 2007 Mar; 91(3):379-84. PubMed ID: 16943225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
